ArticleOrphanet journal of rare diseases2022

Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease.

Harmke A van Kooten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.